Výsledky vyhledávání

Akademický článek

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.

Autor: Geert-Jan Geersing, Janneke M T Hendriksen, Nicolaas P A Zuithoff, Kit C Roes, Ruud Oudega, Toshihiko Takada, Roger E G Schutgens, Karel G M Moons

Publikováno v: PLoS Medicine, Vol 17, Iss 6, p e1003142 (2020)

BackgroundPatients with unprovoked (i.e., without the presence of apparent transient risk factors such as recent surgery) venous thromboembolism (VTE) are at risk of recurrence if anticoagulants are stopped after 3-6 months, yet their risk remains he

Externí odkaz: https://doaj.org/article/b60427eb21234dde89bfc84c0129077e

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

Autor: Michiel L Bots, Diederick E Grobbee, Mark Woodward, Peter J Blankestijn, Andrew Davenport, G Ardine de Wit, Kit C Roes, Kathrin I Fischer, Claudia Barth, Krister Cromm, Bernard Canaud, Jörgen Hegbrant, Matthias Rose, Giovanni FM Strippoli, Robin WM Vernooij

Publikováno v: BMJ Open, Vol 10, Iss 2 (2020)

Introduction End-stage kidney disease (ESKD) is a major public health problem affecting more than 2 million people worldwide. It is one of the most severe chronic non-communicable diseases. Haemodialysis (HD) is the most common therapeutic option but

Externí odkaz: https://doaj.org/article/ebf1fb7ef9d44371b9e3fe22c7f9de5f

Zobrazit plný text záznamu

Akademický článek

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial

Autor: Arno W Hoes, Frans H Rutten, Menno V Huisman, Geert-Jan Geersing, Linda P T Joosten, Sander van Doorn, Melchior C Nierman, Nynke M Wiersma, Huiberdina L Koek, Martin E W Hemels, Kit C Roes, Rutger M van den Bor, Wim F Buding

Publikováno v: BMJ Open, Vol 9, Iss 12 (2019)

Introduction Clinical guidelines recommend non-vitamin K antagonist oral anticoagulants (NOACs) over vitamin K antagonists (VKAs) for stroke prevention in most patients with atrial fibrillation (AF). Frail elderly were under-represented in the landma

Externí odkaz: https://doaj.org/article/6f52ec45918b42bb88865eb7646f4c18

Zobrazit plný text záznamu

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent

Autor: Rik, Rozemeijer, Mera, Stein, Michiel, Voskuil, Rutger, van den Bor, Peter, Frambach, Bruno, Pereira, Stefan, Koudstaal, Geert E, Leenders, Leo, Timmers, Saskia Z, Rittersma, Adriaan O, Kraaijeveld, Pierfrancesco, Agostoni, Kit C, Roes, Pieter A, Doevendans, Pieter R, Stella

Publikováno v: Circulation. 139(1)

Polymer-free amphilimus-eluting stents (PF-AES) represent a novel elution technology in the current era of drug-eluting stents. The clinical safety and efficacy of PF-AES as compared with latest-generation permanent-polymer zotarolimus-eluting stents

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c07cf0c4b92cf6ad4cee67542afd074b
https://pubmed.ncbi.nlm.nih.gov/30586704

Zobrazit plný text záznamu

Dexamethasone for the prevention of postoperative atrial fibrillation

Publikováno v: International Journal of Cardiology, 182, 431. Elsevier Ireland Ltd
International journal of cardiology, 182, 431-437. Elsevier Ireland Ltd

Background: Postoperative atrial fibrillation (AF) is a common complication after cardiac surgery. Inflammation is believed to play a pivotal role in the etiology of postoperative AF. There is a suggestion from small studies that perioperative treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9117235b6a515a7012abf6dcfb0ce2e8
https://doi.org/10.1016/j.ijcard.2014.12.094

Zobrazit plný text záznamu

Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery

Publikováno v: Journal of Thoracic and Cardiovascular Surgery, 153, 878-885.e1
Journal of thoracic and cardiovascular surgery, 153(4), 878-885.e1. Mosby Inc.
van Osch, D, Dieleman, J M, Bunge, J J, van Dijk, D, Doevendans, P A, Suyker, W J, Nathoe, H M & Dexamethasone for Cardiac Surgery Study Group 2017, ' Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery ', Journal of Thoracic and Cardiovascular Surgery, vol. 153, no. 4, pp. 878-885.e1 . https://doi.org/10.1016/j.jtcvs.2016.10.075
Journal of Thoracic and Cardiovascular Surgery, 153(4), 878–885.e1. Mosby Inc.
Journal of Thoracic and Cardiovascular Surgery, 153, 4, pp. 878-885.e1
Journal of Thoracic and Cardiovascular Surgery, 153(4), 878-885.e1. Mosby Inc.
Journal of Thoracic and Cardiovascular Surgery, 153(4), 878-+. Mosby Inc.

Item does not contain fulltext OBJECTIVE: The study aim was to investigate the long-term prognosis and risk factors of postpericardiotomy syndrome (PPS). METHODS: We performed a single-center cohort study in 822 patients undergoing nonemergent valve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1226b663bb27b2f31fcf476a4290f61
https://pubmed.ncbi.nlm.nih.gov/28131509

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání